MAPK3 and Alzheimer disease: ERK1/2 and p38 MAPK-mediated signaling activation elicits neuronal apoptosis during Aβ accumulation in the hippocampus [21,124] and JNK activation can exert anti-apoptotic effects by downregulating mitochondria-dependent caspase-3 activity in an in vitro AD model [120].